Fidelity International’s Takeda Pharmaceutical TAK Stock Holding History

Fidelity International’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-311	Closed	-$6K	–	1066
2020 Q3	$6K	Hold	311	–	–	﹤0.01%	776
2020 Q2	$6K	Hold	311	–	–	﹤0.01%	758
2020 Q1	$5K	Hold	311	–	–	﹤0.01%	726
2019 Q4	$6K	Hold	311	–	–	﹤0.01%	771
2019 Q3	$5K	Hold	311	–	–	﹤0.01%	729
2019 Q2	$6K	Sell	311 -236,487	-100%	-$4.3M	﹤0.01%	730
2019 Q1	$4.82M	Buy	+236,798	New	+$4.77M	0.01%	512

Other funds holding TAK

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Fidelity International's TAK Position: Q4 2020 in Review

Fidelity International sold out of Takeda Pharmaceutical (TAK) in Q4 2020, closing a stake of 311 shares — an estimated $6K sold.

Fidelity International first reported a position in TAK in Q1 2019 and held it in 7 quarters. The position peaked at $4.82M in Q1 2019. 312 funds tracked by Wall St. Rank hold TAK as of Q4 2020.

Fidelity International reported no remaining Takeda Pharmaceutical position as of Q4 2020 after selling out during the quarter.
Fidelity International sold 311 Takeda Pharmaceutical shares in Q4 2020, an estimated $6K.
Fidelity International first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 7 quarters.
Fidelity International's Takeda Pharmaceutical position peaked at $4.82M in Q1 2019.
312 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2020.

Based on Fidelity International's 13F filing for Q4 2020, filed 8 Feb 2021.